The problem
For most Indians, finding the right doctor means word of mouth and a leap of faith: unverified listings, paper-based clinics, and long travel to metros — while tier-2 and tier-3 cities, where demand grows fastest, stay underserved.
How it works
Practo’s platform lets patients discover verified doctors, book in-clinic or video consultations, order medicines and schedule diagnostic tests. On the supply side, doctors and clinics run their practice on Practo’s management software. Seventeen years of transactions now feed a care-navigation layer — in FY25 Practo became the first Indian digital-health company to publish Patient-Reported Outcome Metrics (78% of telemedicine and 80% of physical-consult users reported recovery within three weeks).
Pain points
Unverified providers, appointment lotteries, prescriptions scattered across chemist slips, and zero feedback on treatment outcomes.
Business model
Take-rates across the care transaction (consultations, pharmacy, diagnostics — GMV above ₹3,500 crore) plus recurring SaaS fees from doctors, clinics and hospital front offices.
Challenges
Topline was essentially flat (₹234 crore vs ₹240 crore a year earlier) even as profits arrived; hospital-chain platforms and e-pharmacy giants compete for the same patient; and the new UAE footprint plus US pilots still have to prove the model travels.
Funding
- Raised: ~$228.85M across rounds (Inc42).
- Valuation: MISSING.
Latest — August 2025
In its FY25 annual letter Practo reported its first full year of profitability — ₹15 crore operating EBITDA on ₹234 crore revenue after six consecutive profitable quarters, reversing a ₹17 crore EBITDA loss — alongside ₹3,500 crore+ GMV, 5 crore+ patients and 5 lakh+ verified doctors, reviving long-discussed IPO plans (first flagged in its FY23 annual report).